相关实验视频

Updated: May 28, 2025

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

顺序相同的干细胞移植和化学疗法之间的生存结果,用于形血细胞状树突细胞瘤

Jian Zhou¹, Fengrong Wang¹, Shenmiao Yang¹

¹Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.

Bone marrow transplantation

|February 12, 2025

概括

哈普洛同一性干细胞移植 (HID-SCT) 显著改善了形血细胞状树突细胞瘤 (BPDCN) 患者的治疗结果. 与单独的化疗相比,HID-SCT提供了更高的无进展和整体存活率.

科学领域:

血液学血液学血液学
在瘤学瘤学.
干细胞移植干细胞移植

背景情况:

囊性血细胞状树突细胞瘤 (BPDCN) 是一种罕见的,侵袭性的血液性恶性瘤.
目前对BPDCN的治疗结果往往很差,长期存活数据有限.
在BPDCN中,与化疗相对比较的单一干细胞移植 (HID-SCT) 的比较疗效尚不清楚.

研究的目的:

评估HID-SCT在BPDCN患者中与化疗相比的临床益处.
评估HID-SCT对BPDCN无进展生存 (PFS) 和整体生存 (OS) 的影响.

主要方法:

对32名BPDCN患者的回顾性分析.
对15名接受HID-SCT治疗的患者和仅接受化疗的17名患者进行比较.
分析生存数据,包括PFS和OS.

主要成果:

与化疗组相比,HID-SCT组显示出明显更好的PFS (中位数,未达到) 和OS (中位数,未达到) (PFS中位数,7个月;OS中位数,13个月).
在HID-SCT组中,四年PFS率为74%,OS率为93%,而在化疗组中为0%.
参与BPDCN的常见地点包括皮肤,骨髓和淋巴结.

结论:

HID-SCT是BPDCN的可行和有效的治疗选择.
这项研究表明,HID-SCT可以导致BPDCN患者的长期缓解.
对BPDCN来说,HID-SCT比化疗提供了显著的生存优势.

更多相关视频

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...